Literature DB >> 6370518

Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi.

D Sinha, M Wells, W P Faulk.   

Abstract

Forty human placentae were studied by immunofluorescence for the presence of complement (C) components C1q, C4, C3d, C6 and C9 with the use of characterized antisera. The tissues were grouped as control placentae from 20 normal pregnancies and 20 from cases of pre-eclampsia (PE): the PE samples were sub-grouped as being obtained from patients with mild or severe PE. All of the C components studied were found in the same distribution for test and control samples, but statistical analysis of each pattern of distribution revealed that the deposition of C1q, C3d and C9 were increased in PE as compared to normal tissues. This impression was strengthened by the finding that the deposition of these C components was further increased when chorionic villus immunopathology was compared between mild and severe PE. These data indicate that immunological mechanisms are operating in PE chorionic villi, and they suggest that, among other mechanisms, immune processes may be operative in the pathophysiology of this clinical disease, and that more studies along these lines are in order to rule either in or out this possibility.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370518      PMCID: PMC1535962     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Uteroplacental vasculature.

Authors:  W B Robertson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1976

Review 2.  Recent developments in immunofluorescence.

Authors:  W P Faulk; W Hijmans
Journal:  Prog Allergy       Date:  1972

3.  Complement fixing antibody against solubilized placental microsomal fraction in pre-eclampsia sera.

Authors:  J M Gaugas; P Curzen
Journal:  Br J Exp Pathol       Date:  1974-12

4.  Maternal antibody to fetal light chain (Inv) antigens.

Authors:  W P Faulk; E van Loghem; G B Stickler
Journal:  Am J Med       Date:  1974-03       Impact factor: 4.965

5.  Characterization of rabbit fast and slow 6-6S IgG.

Authors:  W P Faulk; K W Pondman
Journal:  Immunochemistry       Date:  1969-03

6.  Distribution of beta2 microglobulin and HLA in chorionic villi of human placentae.

Authors:  W P Faulk; A Temple
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

7.  Occurrence of trophoblasts in the blood of toxaemic patients.

Authors:  K E Jäämeri; A P Koivuniemi; E O Carpén
Journal:  Gynaecologia       Date:  1965

8.  The pathological response of the vessels of the placental bed to hypertensive pregnancy.

Authors:  W B Robertson; I Brosens; H G Dixon
Journal:  J Pathol Bacteriol       Date:  1967-04

9.  Third component of complement (C3): structural properties in relation to functions.

Authors:  V A Bokisch; M P Dierich; H J Mūller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

10.  Immunohistological and elution studies of the human placenta.

Authors:  J N McCormick; W P Faulk; H Fox; H H Fudenberg
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

View more
  21 in total

1.  An epidemiological study of the immunogenetic aetiology of pre-eclampsia.

Authors:  B W Alderman; R S Sperling; J R Daling
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-08

2.  Polymorphisms in complement genes and risk of preeclampsia in Taiyuan, China.

Authors:  Weiwei Wu; Hailan Yang; Yongliang Feng; Ping Zhang; Shuzhen Li; Xin Wang; Tingting Peng; Fang Wang; Bingjie Xie; Pengge Guo; Mei Li; Ying Wang; Nan Zhao; Dennis Wang; Suping Wang; Yawei Zhang
Journal:  Inflamm Res       Date:  2016-07-12       Impact factor: 4.575

3.  Normal pregnancy is characterized by systemic activation of the complement system.

Authors:  Karina Richani; Eleazar Soto; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

Review 4.  Complement in human reproduction: activation and control.

Authors:  I A Rooney; T J Oglesby; J P Atkinson
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 5.  Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.

Authors:  A M Lynch; J E Salmon
Journal:  Placenta       Date:  2010-04-27       Impact factor: 3.481

6.  Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae.

Authors:  F Tedesco; O Radillo; G Candussi; A Nazzaro; T E Mollnes; D Pecorari
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Sam S Edwin; Yeon Mee Kim; Joon Seok Hong; Luis F Goncalves; Lami Yeo; Moshe Mazor; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

Review 8.  Complement activation and pregnancy failure.

Authors:  Angela Tincani; Ilaria Cavazzana; Tamara Ziglioli; Andrea Lojacono; Valentina De Angelis; Pierluigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

9.  The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro.

Authors:  R Rampersad; A Barton; Y Sadovsky; D M Nelson
Journal:  Placenta       Date:  2008-09-09       Impact factor: 3.481

10.  A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Offer Erez; Juan Pedro Kusanovic; Adi L Tarca; Samuel S Edwin; Jung-Sun Kim; Sonia S Hassan; Jimmy Espinoza; Pooja Mittal; Shali Mazaki-Tovi; Lara Friel; Francesca Gotsch; Edi Vaisbuch; Natalia Camacho; Zoltan Papp
Journal:  Am J Reprod Immunol       Date:  2008-10       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.